Literature DB >> 10553709

Effect of quinolones on intestinal ecology.

C Edlund1, C E Nord.   

Abstract

Quinolones have a selective effect on the normal human intestinal microflora. Published data on 13 different quinolone agents [ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, lomefloxacin, levofloxacin, sparfloxacin, rufloxacin, sitafloxacin (DU-6859a), gatifloxacin, trovafloxacin and moxifloxacin] show that gram-negative aerobic bacteria, especially Enterobacteriaceae, are strongly suppressed or eliminated during therapy. Gram-positive aerobic cocci are affected strongly by administration of sitafloxacin and moxifloxacin and to minor degrees by the other quinolones. Three new quinolones--gatifloxacin, trovafloxacin and moxifloxacin--are very active against anaerobic bacteria in vitro but have minor effects on the anaerobic intestinal human microflora. Similar findings have been reported for the other 10 quinolones. Thus, the quinolone antibacterials have an ecological impact on the human intestinal microflora, mainly on the enterobacteria, that should be taken into account when these agents are used for prophylaxis or treatment of gastrointestinal bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553709     DOI: 10.2165/00003495-199958002-00013

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  24 in total

1.  Influence of pefloxacin on microbial colonization resistance in healthy volunteers.

Authors:  E J Vollaard; H A Clasener; A J Janssen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.

Authors:  C H van Nispen; A I Hoepelman; M Rozenberg-Arska; J Verhoef; L Purkins; S A Willavize
Journal:  Am J Surg       Date:  1998-12       Impact factor: 2.565

3.  Effect of oral ofloxacin on fecal bacteria in human volunteers.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.

Authors:  C Edlund; S Sjöstedt; C E Nord
Journal:  Scand J Infect Dis       Date:  1997

5.  Ecological effect of gatifloxacin on the normal human intestinal microflora.

Authors:  C Edlund; C E Nord
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

6.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery.

Authors:  C Edlund; L Kager; A S Malmborg; S Sjöstedt; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

8.  Norfloxacin for selective decontamination: a study in human volunteers.

Authors:  H G De Vries-Hospers; G W Welling; D Van der Waaij
Journal:  Prog Clin Biol Res       Date:  1985

9.  Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Authors:  M Rozenberg-Arska; A W Dekker; J Verhoef
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

10.  Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

View more
  17 in total

Review 1.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Levofloxacin and moxifloxacin increase human gut colonization by Candida species.

Authors:  George Samonis; Diamantis P Kofteridis; Sofia Maraki; Dimitrios Alegakis; Elpis Mantadakis; John A Papadakis; Achilleas H Gikas; Matthew E Falagas; Matthew Falagas
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents.

Authors:  Michael J Pultz; Michelle M Nerandzic; Usha Stiefel; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

4.  Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.

Authors:  G Garcia-Calvo; A Molleja; M J Giménez; A Parra; E Nieto; C Ponte; L Aguilar; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 5.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 6.  Gatifloxacin: a review of its use in the management of bacterial infections.

Authors:  Caroline M Perry; Douglas Ormrod; Miriam Hurst; Susan V Onrust
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Fluoroquinolones in the elderly: safety considerations.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Levofloxacin: an updated review of its use in the treatment of bacterial infections.

Authors:  Miriam Hurst; Harriet M Lamb; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  Claudia K Hoyen; Nicole J Pultz; David L Paterson; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.

Authors:  Curtis J Donskey; Marion S Helfand; Nicole J Pultz; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.